{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:29:05Z","timestamp":1790972945444,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.psyneuen.2005.11.010","type":"journal-article","created":{"date-parts":[[2006,1,28]],"date-time":"2006-01-28T07:10:36Z","timestamp":1138432236000},"page":"526-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure"],"prefix":"10.1016","volume":"31","author":[{"given":"Matthew N.","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris B.","family":"Gorzalka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2005.11.010_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0006-8993(01)03127-4","article-title":"The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain","volume":"921","author":"Arnold","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1101\/lm.53303","article-title":"Activation of cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse","volume":"10","author":"Azad","year":"2003","journal-title":"Learn. Mem."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0376-8716(99)00150-7","article-title":"Time course for the induction and maintenance of tolerance to Delta9-tetrahydrocannabinol in mice","volume":"60","author":"Bass","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by Delta9-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.npp.1300296","article-title":"Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?","volume":"29","author":"Caberlotto","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0149-7634(01)00011-2","article-title":"A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field","volume":"25","author":"Choleris","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib7","series-title":"Neuropsychopharmacology: The Fifth Generation of Progress","first-page":"931","article-title":"Neural circuitry of anxiety and stress disorders","author":"Davis","year":"2002"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-6147(00)88973-7","article-title":"Use of the elevated plus maze in the search for novel anxiolytic agents","volume":"16","author":"Dawson","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib9","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1046\/j.1460-9568.1999.00645.x","article-title":"Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala","volume":"11","author":"Dayas","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib10","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","article-title":"Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism","volume":"23","author":"Di","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0361-9230(97)00384-5","article-title":"The excitatory effects of the amygdala on hypothalamo\u2013pituitary\u2013adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41","volume":"45","author":"Feldman","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0006-8993(09)90005-1","article-title":"Differential effect of amygdaloid lesions on CRF-41, ACTH and corticosterone responses following neural stimuli","volume":"658","author":"Feldman","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/phrs.1999.0560","article-title":"The cannabinoid agonist HU-210 modifies rat behavioral responses to stress and novelty","volume":"41","author":"Giuliani","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000125260","article-title":"Direct projections from the central amygdaloid nucleus to the hypothalamus paraventricular nucleus: possible role in stress induced adrenocorticotropin secretion","volume":"50","author":"Gray","year":"1989","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/09595230310001613976","article-title":"Being stoned: a review of self-reported cannabis effects","volume":"22","author":"Green","year":"2003","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib16","first-page":"301","article-title":"Emotional response to intravenous delta9-tetrahydrocannabinol during oral surgery","volume":"34","author":"Gregg","year":"1976","journal-title":"J. Oral Surg."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in the rat brain: A quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejphar.2004.06.069","article-title":"Enhancement of the anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress","volume":"499","author":"Hill","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib20","unstructured":"Hill, M.N., Sun, J.C., Tse, M.T.L., Gorzalka, B.B., in press. Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid administration. Int. J. Neuropsychopharmacol, doi:10.1011\/S1461145705005651."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF00401256","article-title":"Effects of (\u2014)delta-9-trans-tetrahydrocannabinol in man","volume":"11","author":"Isbell","year":"1967","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.2042-7158.1979.tb13516.x","article-title":"The effects of delta 9-tetrahydrocannabinol, cannabidiol, and shock on plasma corticosterone concentrations in rats","volume":"31","author":"Jacobs","year":"1979","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib23","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1523\/JNEUROSCI.21-23-09506.2001","article-title":"Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission","volume":"21","author":"Katona","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008877-200402000-00003","article-title":"Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats","volume":"15","author":"Marco","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0091-3057(02)01041-9","article-title":"Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats","volume":"74","author":"Marin","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib26","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0306-4522(01)00380-3","article-title":"Localization of CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons","volume":"107","author":"McDonald","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0278-5846(02)00248-8","article-title":"Anxiogenic effect of median raphe nucleus lesion in stressed rats","volume":"26","author":"Netto","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib30","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/026988110401800407","article-title":"Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats","volume":"18","author":"O'Shea","year":"2004","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib31","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"145","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.npp.1300535","article-title":"Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala","volume":"30","author":"Patel","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib33","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bmj.325.7374.1195","article-title":"Cannabis use and mental health in young people: Cohort study","volume":"325","author":"Patton","year":"2002","journal-title":"Br. Med.J."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib34","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0169-328X(94)90063-9","article-title":"Electrical stimulation of the central nucleus of the amygdala induces fos-like immunoreactivity in the hypothalamus of the rat: a quantitative study","volume":"22","author":"Petrov","year":"1994","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/10253899709013746","article-title":"Hypothalamo\u2013pituitary\u2013adrenocortical regulation following lesions of the central nucleus of the amygdala","volume":"1","author":"Prewitt","year":"1997","journal-title":"Stress"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0891-0618(98)00045-3","article-title":"Anatomical interactions between the central amygdaloid nucleus and the hypothalamus paraventricular nucleus of the rat: a dual tract-tracing analysis","volume":"15","author":"Prewitt","year":"1998","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib38","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1523\/JNEUROSCI.23-25-08800.2003","article-title":"Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons","volume":"23","author":"Quirk","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0031-9384(99)00140-7","article-title":"Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice","volume":"68","author":"Rodgers","year":"1999","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0091-3057(94)90108-2","article-title":"Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment","volume":"47","author":"Rodriguez de Fonseca","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3565(25)12276-3","article-title":"Corticotropin-releasing factor (CRF) antagonist [d-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats","volume":"276","author":"Rodriguez de Fonseca","year":"1996","journal-title":"J. Pharmcol. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib42","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","article-title":"Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal","volume":"276","author":"Rodriguez de Fonseca","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib43","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1152\/jn.2000.83.6.3509","article-title":"Polarized synaptic interactions between intercalated neurons of the amygdala","volume":"83","author":"Royer","year":"2000","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cne.902180202","article-title":"The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat","volume":"218","author":"Sawchenko","year":"1983","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0306-4530(97)00099-1","article-title":"Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load","volume":"23","author":"Schulkin","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-3223(02)01574-3","article-title":"Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs","volume":"53","author":"Singewald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib47","first-page":"427","article-title":"Marijuana sensitivity and panic anxiety","volume":"49","author":"Szuster","year":"1988","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0376-8716(96)01277-X","article-title":"A community survey of adverse effects of cannabis use","volume":"42","author":"Thomas","year":"1996","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib49","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuropharm.2004.01.003","article-title":"Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors","volume":"46","author":"Uriguen","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000125856","article-title":"Amygdaloid lesions: differential effect on conditioned stress and immobilization-induced increases in corticosterone and renin secretion","volume":"54","author":"van der Kar","year":"1991","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(97)00078-4","article-title":"Effect of glucocorticoids on the adrenocortical axis responses to electrical stimulation of the amygdala and the ventral noradrenergic bundle","volume":"754","author":"Weidenfeld","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2005.11.010_bib53","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2165\/00003495-200060060-00005","article-title":"Cannabinoids in clinical practice","volume":"60","author":"Williamson","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.psyneuen.2005.11.010_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453005002477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453005002477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:27:20Z","timestamp":1759681640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453005002477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0306453005002477"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2005.11.010","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2005.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}